Concepedia

Jan Grimm

JG

Statistics

Publications

18

Citations

4.2K

H-Index

14

Active since

1997

Affiliations

University of Zurich(Current)

Light Chain Bioscience (Switzerland)

Swiss Institute for Regenerative Medicine

Biogen (United States)

University of South Florida

Jan Grimm is an author at University of Zurich specializing in life sciences, neurodegeneration, and neuroscience.

ORCID

Publications per year

1997–2024

18

Publications

18

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations

, , +14

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

Andreas Weihofen, Yuting Liu, Joseph W. Arndt et al. · Neurobiology of Disease · 2018 · 198 citations · Full text

, , +17

Deglycosylated Anti-Amyloid-β Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice

Donna M. Wilcock, Jennifer Alamed, Paul E. Gottschall et al. · Journal of Neuroscience · 2006 · 153 citations · Full text

, , +17

NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss

Christian Tackenberg, Sonja Grinschgl, Annette Trutzel et al. · Cell Death and Disease · 2013 · 126 citations · Full text

, , +17

Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro

Chloe K. Nobuhara, Sarah L. DeVos, Caitlin Commins et al. · American Journal Of Pathology · 2017 · 123 citations · Full text

, , +10

1–5 of 18